<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK274566" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK274566/" /><meta name="ncbi_pagename" content="TBC1D24-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>TBC1D24-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="TBC1D24-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/12/07" /><meta name="citation_author" content="Bettina E Mucha" /><meta name="citation_author" content="Raoul CM Hennekam" /><meta name="citation_author" content="Sanjay Sisodiya" /><meta name="citation_author" content="Philippe M Campeau" /><meta name="citation_pmid" content="25719194" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK274566/" /><meta name="citation_keywords" content="DOORS Syndrome" /><meta name="citation_keywords" content="Familial Infantile Myoclonic Epilepsy (FIME)" /><meta name="citation_keywords" content="Progressive Myoclonus Epilepsy (PME)" /><meta name="citation_keywords" content="Early-Infantile Epileptic Encephalopathy 16 (EIEE16)" /><meta name="citation_keywords" content="Autosomal Recessive Nonsyndromic Hearing Loss, DFNB86" /><meta name="citation_keywords" content="Autosomal Dominant Nonsyndromic Hearing Loss, DFNA65" /><meta name="citation_keywords" content="TBC1 domain family member 24" /><meta name="citation_keywords" content="TBC1D24" /><meta name="citation_keywords" content="TBC1D24-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="TBC1D24-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Bettina E Mucha" /><meta name="DC.Contributor" content="Raoul CM Hennekam" /><meta name="DC.Contributor" content="Sanjay Sisodiya" /><meta name="DC.Contributor" content="Philippe M Campeau" /><meta name="DC.Date" content="2017/12/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK274566/" /><meta name="description" content="TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes:" /><meta name="og:title" content="TBC1D24-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="TBC1D24-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK274566/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/tbc1d24-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK274566/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AD381E03F7AC10000000009EE035F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK274566_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK274566_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/tardbp-als/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tfr2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK274566_"><span class="title" itemprop="name"><i>TBC1D24</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Bettina E Mucha</span>, MD, <span itemprop="author">Raoul CM Hennekam</span>, MD, PhD, <span itemprop="author">Sanjay Sisodiya</span>, MD, PhD, and <span itemprop="author">Philippe M Campeau</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK274566_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK274566_ai__"><div class="contrib half_rhythm"><span itemprop="author">Bettina E Mucha</span>, MD<div class="affiliation small">Medical Genetics Service<br />Sainte-Justine Hospital<br />Montreal, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.laertnomu@yn.el-ahcum.ebazile.anitteb" class="oemail">ac.laertnomu@yn.el-ahcum.ebazile.anitteb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Raoul CM Hennekam</span>, MD, PhD<div class="affiliation small">University of Amsterdam<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.avu.cma@makenneh.c.r" class="oemail">ln.avu.cma@makenneh.c.r</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sanjay Sisodiya</span>, MD, PhD<div class="affiliation small">University College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@ayidosis.s" class="oemail">ku.ca.lcu@ayidosis.s</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Philippe M Campeau</span>, MD<div class="affiliation small">Medical Genetics Service<br />Sainte-Justine Hospital<br />Montreal, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.laertnomu@uaepmac.p" class="oemail">ac.laertnomu@uaepmac.p</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 26, 2015</span>; Last Update: <span itemprop="dateModified">December 7, 2017</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="tbc1d24-dis.Summary" itemprop="description"><h2 id="_tbc1d24-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>TBC1D24</i>-related disorders comprise a continuum of features that were originally described as distinct, recognized phenotypes:</p><ul><li class="half_rhythm"><div>DOORS syndrome (<i>d</i>eafness, <i>o</i>nychodystrophy, <i>o</i>steodystrophy, mental <i>r</i>etardation, and <i>s</i>eizures). Profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures</div></li><li class="half_rhythm"><div>Familial infantile myoclonic epilepsy (FIME). Early-onset myoclonic seizures, focal epilepsy, dysarthria, and mild-to-moderate intellectual disability</div></li><li class="half_rhythm"><div>Progressive myoclonus epilepsy (PME). Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia</div></li><li class="half_rhythm"><div>Early-infantile epileptic encephalopathy 16 (EIEE16). Epileptiform EEG abnormalities which themselves are believed to contribute to progressive disturbance in cerebral function</div></li><li class="half_rhythm"><div>Autosomal recessive nonsyndromic hearing loss, DFNB86. Profound prelingual deafness</div></li><li class="half_rhythm"><div>Autosomal dominant nonsyndromic hearing loss, DFNA65. Slowly progressive deafness with onset in the third decade, initially affecting the high frequencies</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>TBC1D24</i>-related disorder is established in an individual with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TBC1D24</i> pathogenic variants when the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (i.e., DOORS syndrome, FIME, PME, EIEE16, and DFNB86), and in an individual with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> when the mode of inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> (DFNA65).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Hearing aids or cochlear implants as needed for hearing loss; early educational intervention and physical, occupational, and speech therapy for developmental delay; symptomatic pharmacologic management for seizures; routine management of visual impairment and renal and cardiac anomalies.</p><p><i>Surveillance:</i> Neurology evaluations with EEGs depending on seizure frequency and/or progression of clinical manifestations; yearly audiologic evaluation to assess for possible progression of hearing loss and/or the efficacy of hearing aids; yearly dental evaluation.</p><p><i>Agents/circumstances to avoid:</i> Excessive ambient noise, which may exacerbate hearing loss in heterozygotes for a <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that causes DFNA65.</p><p><i>Evaluation of relatives at risk:</i> Molecular genetic testing for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from early treatment of seizures and/or hearing loss.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Most <i>TBC1D24</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner (DOORS syndrome, FIME, PME, EIEE16, and DFNB86). For autosomal recessive inheritance: At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives requires prior identification of the <i>TBC1D24</i> pathogenic variants in the family. Prenatal testing is possible for pregnancies at increased risk if the <i>TBC1D24</i> pathogenic variants have been identified in an affected family member.</p></div></div><div id="tbc1d24-dis.GeneReview_Scope"><h2 id="_tbc1d24-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="tbc1d24-dis.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbc1d24-dis.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>TBC1D24</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_tbc1d24-dis.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>DOORS syndrome</div></li><li class="half_rhythm"><div>Familial infantile myoclonic epilepsy (FIME)</div></li><li class="half_rhythm"><div>Progressive myoclonus epilepsy (PME)</div></li><li class="half_rhythm"><div>Early-infantile epileptic encephalopathy 16 (EIEE16)</div></li><li class="half_rhythm"><div>Autosomal recessive nonsyndromic hearing loss, DFNB86</div></li><li class="half_rhythm"><div>Autosomal dominant nonsyndromic hearing loss, DFNA65</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#tbc1d24-dis.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="tbc1d24-dis.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#tbc1d24-dis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="tbc1d24-dis.Diagnosis"><h2 id="_tbc1d24-dis_Diagnosis_">Diagnosis</h2><p><i>TBC1D24</i>-related disorders comprise a continuum of recognized phenotypes:</p><ul><li class="half_rhythm"><div>DOORS syndrome (<i>d</i>eafness, <i>o</i>nychodystrophy, <i>o</i>steodystrophy, mental <i>r</i>etardation, and <i>s</i>eizures)</div></li><li class="half_rhythm"><div>Familial infantile myoclonic epilepsy (FIME)</div></li><li class="half_rhythm"><div>Progressive myoclonus epilepsy (PME)</div></li><li class="half_rhythm"><div>Early-infantile epileptic encephalopathy 16 (EIEE16)</div></li><li class="half_rhythm"><div>Autosomal recessive nonsyndromic hearing loss (DFNB86)</div></li><li class="half_rhythm"><div>Autosomal dominant nonsyndromic hearing loss (DFNA65)</div></li></ul><p>No formal diagnostic criteria have been published for any of the<i>TBC1D24</i>-related disorders.</p><div id="tbc1d24-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>A <i>TBC1D24</i>-related disorder <b>should be suspected</b> in individuals with the following features of the recognized phenotypes that comprise a phenotypic continuum. (Information on additional features appears in <a href="#tbc1d24-dis.Clinical_Characteristics">Clinical Characteristics</a>).</p><p><b>DOORS syndrome</b></p><ul><li class="half_rhythm"><div><i>D</i>eafness (profound sensorineural hearing loss)</div></li><li class="half_rhythm"><div><i>O</i>nychodystrophy (short/absent nails)</div></li><li class="half_rhythm"><div><i>O</i>steodystrophy (short phalanges)</div></li><li class="half_rhythm"><div>Intellectual disability / developmental delay (formerly known as mental <i>r</i>etardation)</div></li><li class="half_rhythm"><div><i>S</i>eizures</div></li><li class="half_rhythm"><div>2-oxoglutaric aciduria</div></li></ul><p><b>Familial infantile myoclonic epilepsy (FIME).</b> Early-onset myoclonic seizures</p><p><b>Progressive myoclonus epilepsy (PME).</b> Action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia</p><p><b>Early-infantile epileptic encephalopathy 16 (EIEE16)</b></p><ul><li class="half_rhythm"><div>Early-onset seizures (unresponsive to medication) that can include myoclonic seizures or malignant migrating partial seizures of infancy</div></li><li class="half_rhythm"><div>Extrapyramidal signs (e.g., dystonia), hemiparesis, and/or autonomic signs</div></li><li class="half_rhythm"><div>Neurologic deterioration and early death</div></li><li class="half_rhythm"><div>Progressive diffuse cerebral atrophy</div></li></ul><p><b>Autosomal recessive nonsyndromic hearing loss, DFNB86.</b> Prelingual nonsyndromic sensorineural deafness (See <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>.)</p><p><b>Autosomal dominant nonsyndromic hearing loss, DFNA65.</b> Adult-onset nonsyndromic sensorineural deafness (See <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>.)</p></div><div id="tbc1d24-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>TBC1D24</i>-related disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of (<a class="figpopup" href="/books/NBK274566/table/tbc1d24-dis.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figtbc1d24disTmoleculargenetictesting" rid-ob="figobtbc1d24disTmoleculargenetictesting">Table 1</a>):</p><ul><li class="half_rhythm"><div>Biallelic pathogenic variants in <i>TBC1D24</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> when the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (i.e., DOORS syndrome, FIME, PME, EIEE16, and DFNB86);</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> when the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> (DFNA65).</div></li></ul><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>TBC1D24</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div><div class="half_rhythm">Note: (1) The diagnostic yield appears to be highest in individuals with all five typical features of DOORS syndrome [<a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>]. (2) The proportion of epilepsy caused by pathogenic variants in <i>TBC1D24</i> appears to be small, and clinically distinctive signs and symptoms have not yet been identified.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TBC1D24</i> and other genes of interest (see <a href="#tbc1d24-dis.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="tbc1d24-dis.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>TBC1D24</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TBC1D24</i></td><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>DOORS syndrome: 9/18 families w/all 5 major features&#x000a0;<sup>4</sup></div></li><li class="half_rhythm"><div>FIME: rare&#x000a0;<sup>5,&#x000a0;6</sup></div></li><li class="half_rhythm"><div>PME: rare&#x000a0;<sup>5,&#x000a0;7</sup></div></li><li class="half_rhythm"><div>EIEE16: rare&#x000a0;<sup>5,&#x000a0;8</sup></div></li><li class="half_rhythm"><div>DFNB86: rare&#x000a0;<sup>5,&#x000a0;9</sup></div></li><li class="half_rhythm"><div>DFNA65: rare&#x000a0;<sup>5,&#x000a0;10</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>11</sup></td><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>12</sup></td></tr><tr><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>13</sup></td><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_tbc1d24-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">EIEE = early-infantile epileptic encephalopathy; FIME = <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile myoclonic epilepsy; PME = progressive myoclonus epilepsy</p></div></dd><dt>1. </dt><dd><div id="tbc1d24-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK274566/#tbc1d24-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="tbc1d24-dis.TF.1.2"><p class="no_margin">See <a href="#tbc1d24-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="tbc1d24-dis.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="tbc1d24-dis.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al [2014]</a></p></div></dd><dt>5. </dt><dd><div id="tbc1d24-dis.TF.1.5"><p class="no_margin">Although a significant proportion of individuals with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have a genetic etiology, <i>TBC1D24</i> is a rare cause.</p></div></dd><dt>6. </dt><dd><div id="tbc1d24-dis.TF.1.6"><p class="no_margin">Three families reported [<a class="bk_pop" href="#tbc1d24-dis.REF.corbett.2010.371">Corbett et al 2010</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.falace.2010.365">Falace et al 2010</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.afawi.2013.240">Afawi et al 2013</a>]</p></div></dd><dt>7. </dt><dd><div id="tbc1d24-dis.TF.1.7"><p class="no_margin">One family reported [<a class="bk_pop" href="#tbc1d24-dis.REF.muona.2015.39">Muona et al 2015</a>]</p></div></dd><dt>8. </dt><dd><div id="tbc1d24-dis.TF.1.8"><p class="no_margin">Three families reported [<a class="bk_pop" href="#tbc1d24-dis.REF.guven.2013.199">Guven &#x00026; Tolun 2013</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.milh.2013.869">Milh et al 2013</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.lozano.2016.3207">Lozano et al 2016</a>]; one individual in a cohort of 359 individuals with epileptic encephalopathy [<a class="bk_pop" href="#tbc1d24-dis.REF.de_kovel.2016.568">de Kovel et al 2016</a>]</p></div></dd><dt>9. </dt><dd><div id="tbc1d24-dis.TF.1.9"><p class="no_margin">Recessive deafness; five families reported [<a class="bk_pop" href="#tbc1d24-dis.REF.rehman.2014.144">Rehman et al 2014</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.bakhchane.2015.e0138072">Bakhchane et al 2015</a>]</p></div></dd><dt>10. </dt><dd><div id="tbc1d24-dis.TF.1.10"><p class="no_margin">Dominant deafness; two families reported [<a class="bk_pop" href="#tbc1d24-dis.REF.azaiez.2014.819">Azaiez et al 2014</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.zhang.2014.814">Zhang et al 2014</a>]</p></div></dd><dt>11. </dt><dd><div id="tbc1d24-dis.TF.1.11"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>12. </dt><dd><div id="tbc1d24-dis.TF.1.12"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>13. </dt><dd><div id="tbc1d24-dis.TF.1.13"><p class="no_margin">Genetic heterogeneity for DOORS syndrome is likely. Exome analysis in some of these families did not reveal a commonly mutated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>], but an extension of this study is ongoing.</p></div></dd></dl></div></div></div></div></div><div id="tbc1d24-dis.Clinical_Characteristics"><h2 id="_tbc1d24-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="tbc1d24-dis.Clinical_Description"><h3>Clinical Description</h3><p>While initial reports suggested specific phenotypes associated with pathogenic variants in <i>TBC1D24</i>, several recent publications suggest that the features represent a phenotypic spectrum ranging from a mild form of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile myoclonic epilepsy (FIME) to a combination of epilepsy with variable other features, to DOORS syndrome [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>]. Features seen in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TBC1D24</i> pathogenic variants who do not have DOORS syndrome include parkinsonism [<a class="bk_pop" href="#tbc1d24-dis.REF.banuelos.2017.553">Banuelos et al 2017</a>], ataxia, dysarthria, axial hypotonia, hearing loss, visual impairment, mild <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, developmental delay or intellectual disability, and microcephaly [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>].</p><div id="tbc1d24-dis.DOORS_Syndrome"><h4>DOORS Syndrome</h4><p><b>The five major features of DOORS syndrome</b> are profound sensorineural hearing loss, onychodystrophy, osteodystrophy, intellectual disability / developmental delay, and seizures [<a class="bk_pop" href="#tbc1d24-dis.REF.james.2007.2821">James et al 2007</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>].</p><p>The sensorineural hearing loss is often profound and prelingual. Some have benefited from cochlear implants.</p><p>The onychoosteodystrophy affects the hands and feet equally. Small or absent nails (onychodystrophy) and hypoplastic terminal phalanges (osteodystrophy) are noted in most individuals. A triphalangeal thumb is present in one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p>The intellectual disability (previously referred to as mental retardation) can vary significantly in degree but is often severe [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>]. The motor and language skills were most delayed in two children where such details are available [<a class="bk_pop" href="#tbc1d24-dis.REF.nomura.2009.75">Nomura et al 2009</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.girish.2011.479">Girish et al 2011</a>]. One child had autism spectrum disorder [<a class="bk_pop" href="#tbc1d24-dis.REF.nomura.2009.75">Nomura et al 2009</a>].</p><p>Seizures, present in most individuals with DOORS syndrome, usually start in the first year of life. The seizures are more often generalized tonic-clonic, but myoclonic, partial, and absence seizures also occur. Occasionally their frequency or severity increases. In several instances, the seizures have been difficult to control even with multiple antiepileptic medications, and have led to status epilepticus and death.</p><p>On MRI hyperintense T<sub>2</sub>-weighted signal anomalies may be observed in the cerebellar hemispheres and the frontal region [<a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>].</p><p><b>Nonspecific <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features.</b> A wide nasal base and a bulbous nose are the most common facial dysmorphisms. Other findings in a minority of individuals include narrow forehead, narrow or high arched palate, broad alveolar ridge, short frenulum, and nevus simplex on the glabella and nose.</p><p><b>Other.</b> In individuals with DOORS syndrome the additional anomalies noted are the following:</p><ul><li class="half_rhythm"><div>Microcephaly in one third of individuals</div></li><li class="half_rhythm"><div>Other cranial anomalies (sagittal craniosynostosis in 1 individual; frontal bossing, trigonocephaly, or brachycephaly in several other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li><li class="half_rhythm"><div>Dental anomalies (delayed eruption, wide spacing, and abnormal shape, size, and number)</div></li><li class="half_rhythm"><div>Congenital heart defects (double outlet right ventricle)</div></li><li class="half_rhythm"><div>Skeletal anomalies (e.g., calcaneal deformities)</div></li><li class="half_rhythm"><div>Hypothyroidism</div></li><li class="half_rhythm"><div>Renal and urinary tract anomalies (e.g., hydronephrosis, nephrocalcinosis) [<a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>]</div></li><li class="half_rhythm"><div>Elevated levels of urinary 2-oxoglutaric acid, which can fluctuate between normal and elevated over time [<a class="bk_pop" href="#tbc1d24-dis.REF.patton.1987.207">Patton et al 1987</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.van_bever.2007.763">van Bever et al 2007</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>]</div></li><li class="half_rhythm"><div>Visual impairment in six of 14 individuals [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>]</div></li><li class="half_rhythm"><div>Peripheral neuropathy in one individual with confirmed <i>TBC1D24</i> pathogenic variants [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et la 2016</a>] and three individuals who either did not undergo genetic testing or in whom no <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified</div></li></ul></div><div id="tbc1d24-dis.Familial_Infantile_Myoclonic"><h4>Familial Infantile Myoclonic Epilepsy (FIME)</h4><p>FIME is characterized by early-onset myoclonic seizures.</p><p>Findings include focal epilepsy, dysarthria, mild-to-moderate intellectual disability, and cortical thickening and cerebellar atrophy with high T<sub>2</sub>-weighted and FLAIR on MRI (in 4 sibs of an Israeli Arab family [<a class="bk_pop" href="#tbc1d24-dis.REF.corbett.2010.371">Corbett et al 2010</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.afawi.2013.240">Afawi et al 2013</a>]).</p><p>Intellect may be normal: all seven members of an Italian family who had FIME and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TBC1D24</i> pathogenic variants also had normal intelligence. Six had normal brain MRI and one had periventricular nodular heterotopia [<a class="bk_pop" href="#tbc1d24-dis.REF.zara.2000.1552">Zara et al 2000</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.de_falco.2001.1541">de Falco et al 2001</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.falace.2010.365">Falace et al 2010</a>].</p></div><div id="tbc1d24-dis.Progressive_Myoclonus_Epilep"><h4>Progressive Myoclonus Epilepsy (PME)</h4><p>PME is characterized by action myoclonus, tonic-clonic seizures, progressive neurologic decline, and ataxia.</p><p>For the child described with PME caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TBC1D24</i>, tonic seizures started at age 36 hours. Developmental delay with later regression was then noted. Myoclonus started at age eight months and tonic-clonic seizures at age 3.5 years. Ataxia, spasticity, supranuclear gaze palsy, and visual decline were also noted. Although the initial clinical diagnosis was of an epileptic encephalopathy, a florid PME pattern was apparent by age nine years [<a class="bk_pop" href="#tbc1d24-dis.REF.muona.2015.39">Muona et al 2015</a>]. There were no digital anomalies or deafness [Sam Berkovic, MD, personal communication].</p></div><div id="tbc1d24-dis.EarlyInfantile_Epileptic_Enc"><h4>Early-Infantile Epileptic Encephalopathy 16 (EIEE16)</h4><p>Epileptic encephalopathies are defined by the International League Against Epilepsy (ILAE) as conditions in which epileptiform EEG abnormalities themselves are believed to contribute to progressive disturbance in cerebral function [<a class="bk_pop" href="#tbc1d24-dis.REF.engel.2001.796">Engel 2001</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.berg.2010.676">Berg et al 2010</a>].</p><p>Findings may include:</p><ul><li class="half_rhythm"><div>Myoclonic epilepsy with episodic dystonia, hemiparesis, autonomic signs, and lethargy evolving to chronic dystonia, progressive diffuse cerebral atrophy, and early death (in 5 Turkish families [<a class="bk_pop" href="#tbc1d24-dis.REF.duru.2010.207">Duru et al 2010</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.guven.2013.199">Guven &#x00026; Tolun 2013</a>]);</div></li><li class="half_rhythm"><div>Malignant migrating partial seizures in infancy with progressive diffuse cerebral atrophy of the gray matter (sparing the posterior fossa) and early death (in 2 French sibs [<a class="bk_pop" href="#tbc1d24-dis.REF.milh.2013.869">Milh et al 2013</a>]).</div></li></ul></div><div id="tbc1d24-dis.Autosomal_Recessive_Nonsyndr"><h4>Autosomal Recessive Nonsyndromic Hearing Loss, DFNB86</h4><p>Findings observed include profound prelingual deafness with hearing thresholds above 90 dB for all test frequencies (in 2 <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Pakistani families; 1 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member and 1 individual with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> also had seizures [<a class="bk_pop" href="#tbc1d24-dis.REF.rehman.2014.144">Rehman et al 2014</a>]) (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>).</p></div><div id="tbc1d24-dis.Autosomal_Dominant_Nonsyndro"><h4>Autosomal Dominant Nonsyndromic Hearing Loss, DFNA65</h4><p>Findings include slowly progressive deafness with onset in the third decade, initially affecting the high frequencies (in 1 Chinese family [<a class="bk_pop" href="#tbc1d24-dis.REF.zhang.2014.814">Zhang et al 2014</a>] and in a family of European descent [<a class="bk_pop" href="#tbc1d24-dis.REF.azaiez.2014.819">Azaiez et al 2014</a>]) (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>).</p><p><b>Heterozygotes, in the context of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disease.</b> Two unrelated individuals with generalized tonic-clonic seizures and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic <i>TBC1D24</i> variants both had a family history of hearing loss, but the relatives with hearing loss were not tested for a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In one family, the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's brother had hearing loss and in the other family the affected individual's maternal grandmother had hearing loss [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>].</p><p>Increasing evidence points to an elevated susceptibility to seizure disorders in apparently unaffected individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., a "<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>") as compared to the population frequency estimated at seven per 1,000 individuals.</p><ul><li class="half_rhythm"><div>In a family with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hearing loss, an individual with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic <a class="figpopup" href="/books/NBK274566/table/tbc1d24-dis.T.tbc1d24_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figtbc1d24disTtbc1d24pathogenicvariant" rid-ob="figobtbc1d24disTtbc1d24pathogenicvariant">p.Asp70Tyr</a> variant developed seizures starting at age three years [<a class="bk_pop" href="#tbc1d24-dis.REF.rehman.2014.144">Rehman et al 2014</a>].</div></li><li class="half_rhythm"><div>A family history of seizures was also reported in two families with DOORS syndrome, including a mother who was <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="figpopup" href="/books/NBK274566/table/tbc1d24-dis.T.tbc1d24_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figtbc1d24disTtbc1d24pathogenicvariant" rid-ob="figobtbc1d24disTtbc1d24pathogenicvariant">c.1008delT</a> variant with absence seizures in childhood [<a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>] and a heterozygous father [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>, supplemental material].</div></li><li class="half_rhythm"><div>Family history was positive in an additional five families with <i>TBC1D24</i> pathogenic variants; family members were unavailable for sequencing [<a class="bk_pop" href="#tbc1d24-dis.REF.stra_i_ar.2015.251">Stra&#x0017e;i&#x00161;ar et al 2015</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>, supplemental material].</div></li><li class="half_rhythm"><div>Finally, in a family with an atypical neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, both the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's mother and her brother had seizures in childhood and adolescence, respectively. Both were confirmed to have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> novel <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK274566/table/tbc1d24-dis.T.tbc1d24_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figtbc1d24disTtbc1d24pathogenicvariant" rid-ob="figobtbc1d24disTtbc1d24pathogenicvariant">p.Pro135Leu</a>) [<a class="bk_pop" href="#tbc1d24-dis.REF.banuelos.2017.553">Banuelos et al 2017</a>].</div></li></ul></div></div><div id="tbc1d24-dis.GenotypePhenotype_Correlatio"><h3>Genotype-Phenotype Correlations</h3><p>The <i>TBC1D24</i> pathogenic variants that cause DOORS syndrome, FIME, EIEE16, DFNB86, and DFNA65 are located throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; no pattern has emerged to date. Most pathogenic variants causing one <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have not been demonstrated to cause the others, either within the same family or in different families. However, a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a> (c.1008delT) coupled with another <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> affecting the other <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> was identified in four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, two with DOORS and one sib pair with EIEE16 and early death.</p><p>In general, <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants (frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, or <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>) are associated with a more severe epilepsy <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with drug resistance and early death, except when the loss-of-function variant is located in the last <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in or before the TBC <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> are also associated with a higher risk of lethality.</p><p>The diagnosis of DOORS does not allow for a prediction of the epilepsy type [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>]. The location of new pathogenic variants cannot yet be used to predict a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. This may change as more pathogenic variants are identified.</p></div><div id="tbc1d24-dis.Nomenclature"><h3>Nomenclature</h3><p>The acronym "DOOR syndrome" was coined in 1975 [<a class="bk_pop" href="#tbc1d24-dis.REF.cantwell.1975.261">Cantwell 1975</a>]. Subsequently, <a class="bk_pop" href="#tbc1d24-dis.REF.qazi.1984.391">Qazi &#x00026; Nangia [1984]</a> suggested adding an S (DOORS syndrome) because of the seizures present in most individuals. Other terms used for this condition include digito-reno-cerebral syndrome [<a class="bk_pop" href="#tbc1d24-dis.REF.eronen.1985.281">Eronen et al 1985</a>] and Eronen syndrome [<a class="bk_pop" href="#tbc1d24-dis.REF.le_merrer.1992.196">Le Merrer et al 1992</a>].</p><p>EIEE16 has also been referred to as malignant migrating partial seizures of infancy (MMPSI) [<a class="bk_pop" href="#tbc1d24-dis.REF.milh.2013.869">Milh et al 2013</a>], which is also known as epilepsy of infancy with migrating focal seizures.</p></div><div id="tbc1d24-dis.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>TBC1D24</i>-related disorders is very low. Fewer than 50 families with DOORS syndrome are known, and fewer than five each for the other <i>TBC1D24</i>-related disorders. A targeted sequencing study of a cohort of 359 individuals with epileptic encephalopathy identified one person with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TBC1D24</i> variants [<a class="bk_pop" href="#tbc1d24-dis.REF.de_kovel.2016.568">de Kovel et al 2016</a>].</p></div></div><div id="tbc1d24-dis.Genetically_Related_Allelic"><h2 id="_tbc1d24-dis_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>All the phenotypes known to be associated with pathogenic variants in <i>TBC1D24</i> are included in this <i>GeneReview</i>.</p></div><div id="tbc1d24-dis.Differential_Diagnosis"><h2 id="_tbc1d24-dis_Differential_Diagnosis_">Differential Diagnosis</h2><div id="tbc1d24-dis.DOORS_Syndrome_1"><h3>DOORS Syndrome</h3><div id="tbc1d24-dis.T.disorders_to_consider_in_t" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of DOORS Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.T.disorders_to_consider_in_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.T.disorders_to_consider_in_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential Diagnosis Disorder</th><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4" id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/DOORS syndrome</th><th headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4" id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from DOORS syndrome</th></tr></thead><tbody><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/coffin-siris/">Coffin-Siris syndrome</a><br />(see also <a href="/books/n/gene/arid1b-dis/"><i>ARID1B</i>-Related Disorder</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARID1A</i><br /><i>ARID1B</i><br /><i>SMARCA4</i><br /><i>SMARCB1</i><br /><i>SMARCE1</i><br /><i>SOX11</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1</sup></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID/DD, aplastic or hypoplastic nails &#x00026; terminal phalanges, seizures</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variably seen: coarse face, generalized hypertrichosis, scoliosis (some), gingival overgrowth (some), &#x00026; 5th finger hypoplasia</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dominant deafness-<br />onychodystrophy syndrome<br />(OMIM <a href="http://omim.org/entry/124480" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">124480</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP6V1B2</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital sensorineural deafness, onychodystrophy</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental anomalies (conical, hypoplastic teeth) (some); absence of ID/DD &#x00026; seizures</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/nbs/">Nicolaides-Baraitser syndrome</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMARCA2</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1</sup></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe ID/DD, seizures</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Coarse face, prominent &#x0fb01;nger joints &#x00026; broad distal phalanges, scoliosis (some)</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Temple-Baraitser syndrome<br />(OMIM <a href="http://omim.org/entry/611816" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">611816</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNH1</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1</sup></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe ID/DD, seizures, nail hypoplasia/aplasia limited to 1st rays (thumb, great toe)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Broad and proximally implanted thumbs, long great toes</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Zimmermann-Laband syndrome<br />(OMIM <a href="http://omim.org/entry/135500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">135500</a> and <a href="http://omim.org/entry/616455" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616455</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNH1</i><br /><i>ATP6B1B2</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable ID/DD, seizures in ZLS due to pathogenic variants in <i>KCNH1</i>, hypoplasia or aplasia of nails &#x00026; terminal phalanges, hearing loss (some)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Coarse face, hypertrichosis, gingival overgrowth, scoliosis; no seizures in individuals w/ZLS caused by pathogenic variants in <i>ATP6B1B2</i></td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mabry syndrome<br />(OMIM <a href="http://omim.org/entry/239300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">239300</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PIGV</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe ID/DD, seizures, short terminal phalanges, and nail hypoplasia</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperphosphatasia; absence of 2-oxoglutaric aciduria &#x00026; deafness</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kaufman oculocerebrofacial<br />syndrome<br />(OMIM <a href="http://omim.org/entry/244450" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">244450</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>UBE3B</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID/DD, hearing loss (some), microcephaly, nail dysplasia</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Blepharophimosis; hypoplastic/absent terminal phalanges rarely seen</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fetal anticonvulsant syndrome</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">n/a</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">n/a</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID/DD, nail hypoplasia</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental abnormalities w/delayed eruption, talipes equinovarus, otitis media w/effusion; absence of hearing loss &#x00026; seizures</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ID/DD = intellectual disability / developmental delay; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="tbc1d24-dis.TF.2.1"><p class="no_margin">Pathogenic variants are typically (or always) <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</p></div></dd></dl></div></div></div><div id="tbc1d24-dis.T.other_conditions_with_2oxo" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Other Conditions with 2-Oxoglutaric Aciduria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.T.other_conditions_with_2oxo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.T.other_conditions_with_2oxo_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential Diagnosis Disorder</th><th id="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4" id="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>TBC1D24</i>-related disorders</th><th headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4" id="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>TBC1D24</i>-related disorders</th></tr></thead><tbody><tr><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Combined D-2- and<br />L-2-hydroxyglutaric aciduria<br />(OMIM <a href="http://omim.org/entry/615182" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615182</a>)</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A1</i></td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4 hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe DD, seizures</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4 hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe neonatal encephalopathy w/early death, no skeletal manifestations, &#x02191; D-2- &#x00026; L-2-hydroxyglutaric acid</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-methylcrotonyl-CoA<br />carboxylase 1 deficiency<br />(OMIM <a href="http://omim.org/entry/210200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">210200</a>)</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MCCC1</i></td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4 hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-oxoglutaric aciduria in 1 individual; ID, DD, seizures</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4 hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Urinary excretion of 3-hydroxyisovalerate &#x00026; 3-methylcrotonylglycine, metabolic decompensation</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-ketoglutarate<br />dehydrogenase deficiency<br />(OMIM <a href="http://omim.org/entry/203740" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">203740</a>)</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4 hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Elevated 2-oxoglutaric acid</td><td headers="hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_1_4 hd_h_tbc1d24-dis.T.other_conditions_with_2oxo_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive neurodegenerative disorder; development initially normal</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd></dl></div></div></div></div><div id="tbc1d24-dis.Familial_Infantile_Myoclonic_1"><h3>Familial Infantile Myoclonic Epilepsy (FIME) and Progressive Myoclonus Epilepsy (PME)</h3><div id="tbc1d24-dis.T.disorders_to_consider_in_t_1" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>TBC1D24</i>-Related FIME and <i>TBC1D24</i>-Related PME</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.T.disorders_to_consider_in_t_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.T.disorders_to_consider_in_t_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential Diagnosis Disorder</th><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4" id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>TBC1D24-</i>related FIME/PME</th><th headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4" id="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>TBC1D24-</i>related FIME/PME</th></tr></thead><tbody><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Juvenile myoclonic epilepsy<br />(OMIM <a href="http://omim.org/entry/254770" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">254770</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EFHC1</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonic seizures, generalized tonic-clonic seizures</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typical 3-Hz polyspike EEG, normal intelligence, later mean age of onset (~10 yrs), myoclonic seizures (jerks) typically in the morning</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-infantile myoclonic encephalopathy 3<br />(OMIM <a href="http://omim.org/entry/609304" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609304</a>)</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A22</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonic refractory seizures, early onset age</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Burst suppression on EEG, abnormal visual evoked potentials, spasticity</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/epm1/">Unverricht-Lundborg disease</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CSTB</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Generalized tonic-clonic seizures, myoclonic seizures</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No or mild decline in intellectual performance, EEG always abnormal, later onset age</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lafora/">Progressive myoclonus epilepsy, Lafora type</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EPM2A</i><br /><i>NHLRC1</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Generalized myoclonus and/or generalized tonic-clonic seizures</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive neurologic degeneration in previously healthy adolescents; Lafora bodies</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuronal ceroid-lipofuscinoses</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP13A2</i><br /><i>CLN3</i><br /><i>CLN5</i><br /><i>CLN6</i><br /><i>CLN8</i><br /><i>CTSD</i><br /><i>CTSF</i><br /><i>DNAJC5</i><br /><i>GRN</i><br /><i>KCTD7</i><br /><i>MFSD8</i><br /><i>PPT1</i><br /><i>TPP1</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR&#x000a0;<sup>1</sup></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus, seizures</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive intellectual &#x00026; motor deterioration w/vision loss</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/merrf/">MERRF</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TF</i><br /><i>MT-TI</i><br /><i>MT-TK</i><br /><i>MT-TL1</i><br /><i>MT-TP</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mat</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus, generalized epilepsy, hearing loss, ataxia</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal early development, ragged-red fibers on muscle biopsy, lactic acidosis; cardiomyopathy in some</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/"><i>POLG</i>-related disorders</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonus, seizures, ataxia</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that may incl ophthalmoplegia, neuropathy, liver dysfunction</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gefs/"><i>SCN1A</i>-related seizure disorders</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN1A</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonic epilepsy, generalized tonic-clonic/ hemiclonic &#x00026; focal seizures</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not assoc w/hearing loss</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/amrf/">Action myoclonus-renal failure syndrome</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCARB2</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive myoclonic epilepsy</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Onset in late teens or early 20s w/tremors, proteinuria, &#x00026; development of renal failure possible</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/me-ataxia/"><i>PRICKLE1</i>-related progressive myoclonus epilepsy with ataxia</a></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRICKLE1</i></td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoclonic seizures, generalized convulsive seizures, ataxia</td><td headers="hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_1_4 hd_h_tbc1d24-dis.T.disorders_to_consider_in_t_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal intellect</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; Mat = maternal; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="tbc1d24-dis.TF.4.1"><p class="no_margin">Neuronal ceroid-lipofuscinosis (NCL) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner with the exception of adult NCL, which can be inherited in either an autosomal recessive or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div></dd></dl></div></div></div></div><div id="tbc1d24-dis.EarlyInfantile_Epileptic_Enc_1"><h3>Early-Infantile Epileptic Encephalopathy (EIEE)</h3><p>EIEE is a rare form of epilepsy in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children develop intractable seizures in the first weeks or months of life resulting in severe developmental disabilities or death in infancy.</p><p>EIEE is genetically heterogeneous. Causes can include the following:</p><ul><li class="half_rhythm"><div>Rare copy number variations [<a class="bk_pop" href="#tbc1d24-dis.REF.mefford.2011.974">Mefford et al 2011</a>]</div></li><li class="half_rhythm"><div>Mutation of an individual <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that may be rare, with fewer than five <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families identified (e.g., <a href="http://omim.org/entry/606494" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>ST3GAL3</i></a> (EIEE15), <a href="http://omim.org/entry/139311" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>GNAO1</i></a> (EIEE17), or <a href="http://omim.org/entry/615463" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>SZT2</i></a> (EIEE18)</div></li><li class="half_rhythm"><div>Mutation of an individual <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that may affect hundreds of individuals (e.g., <i>SCN1A</i> (<a href="/books/n/gene/gefs/">Dravet syndrome</a>) [<a class="bk_pop" href="#tbc1d24-dis.REF.brunklaus.2012.2329">Brunklaus et al 2012</a>]</div></li><li class="half_rhythm"><div>Metabolic causes of epileptic encephalopathies such as <a href="/books/n/gene/nkh/">glycine encephalopathy</a>, <a href="/books/n/gene/biotin/">biotinidase deficiency</a>, organic acidemias, cerebral folate deficiency, and <a href="/books/n/gene/pds/">pyridoxine-dependent epilepsy</a> [<a class="bk_pop" href="#tbc1d24-dis.REF.yu.2013.124934">Yu &#x00026; Pearl 2013</a>]</div></li></ul><p>See <a href="http://omim.org/phenotypicSeries/PS308350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epileptic encephalopathy, early-infantile &#x02013; OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div><div id="tbc1d24-dis.Hereditary_Hearing_Loss_and"><h3>Hereditary Hearing Loss and Deafness</h3><p>For the differential diagnosis of hereditary hearing loss and deafness, see <a href="/books/n/gene/deafness-overview/">Hereditary Deafness and Hearing Loss Overview</a>.</p></div></div><div id="tbc1d24-dis.Management"><h2 id="_tbc1d24-dis_Management_">Management</h2><div id="tbc1d24-dis.Evaluations_Following_Initia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>TBC1D24</i>-related disorder, the following evaluations are recommended if they have not already been completed:</p><p><b>DOORS syndrome</b></p><ul><li class="half_rhythm"><div>Audiology evaluation</div></li><li class="half_rhythm"><div>Ophthalmology evaluation</div></li><li class="half_rhythm"><div>Dental examination</div></li><li class="half_rhythm"><div>Otolaryngology consultation</div></li><li class="half_rhythm"><div>Echocardiogram</div></li><li class="half_rhythm"><div>Renal ultrasound examination</div></li><li class="half_rhythm"><div>Neurology consultation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p><b>FIME, PME, EIEE16,</b> and <b><i>TBC1D24</i>-related nonsyndromic deafness syndromes (DFNA65</b> and <b>DFNB86).</b> One should consider some of the above evaluations depending on the signs and symptoms, since clinical overlap between all <i>TBC1D24</i>-related conditions exists.</p></div><div id="tbc1d24-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Deafness.</b> Consider hearing aids or cochlear implants as needed for hearing loss (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>). Cochlear implants at age one have been beneficial in one individual with DOORS syndrome [<a class="bk_pop" href="#tbc1d24-dis.REF.campeau.2014.44">Campeau et al 2014</a>].</p><p><b>Visual impairment</b> should be managed in the standard fashion.</p><p><b>Heart defects</b> should be managed according to the anomalies detected.</p><p><b>Renal anomalies.</b> Refer to an urologist or nephrologist, as indicated.</p><p><b>Seizures.</b> Symptomatic pharmacologic management is warranted, as no controlled studies have compared the efficacy of different antiepileptic drugs in <i>TBC1D24</i>-related disorders. A variety of different antiepileptic agents have been used to achieve seizure control [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>].</p><p>The management of epilepsy in many genetic epilepsies is complex; general recommendations from the UK National Institute for Health and Care Excellence are available <a href="http://www.nice.org.uk/guidance/cg137" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>.</p><div id="tbc1d24-dis.Developmental_Delay__Intelle"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, and speech therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an individualized education program (IEP) based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="tbc1d24-dis.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="tbc1d24-dis.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p></div></div><div id="tbc1d24-dis.Surveillance"><h3>Surveillance</h3><p>Neurology evaluations with EEGs are appropriate, depending on seizure frequency and/or progression of clinical manifestations. Individuals with epilepsy, irrespective of cause, should have periodic ECGs as interictal and ictal abnormalities may predispose to sudden unexplained death in epilepsy (SUDEP).</p><p>Perform yearly audiologic evaluation to assess for possible progression of hearing loss and/or the efficacy of hearing aids.</p><p>Yearly dental evaluation is appropriate.</p></div><div id="tbc1d24-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Heterozygotes for a <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> causing <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> deafness, DFNA65 should avoid excessive ambient noise as it may exacerbate hearing loss.</p></div><div id="tbc1d24-dis.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>Molecular genetic testing for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is appropriate in order to identify as early as possible those who would benefit from early treatment of seizures and/or deafness.</p><p>See <a href="#tbc1d24-dis.Related_Genetic_Counseling_I">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="tbc1d24-dis.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In general, no information on specific prenatal presentations is available.</p><p>Polyhydramnios is often noted when a fetus has DOORS syndrome [<a class="bk_pop" href="#tbc1d24-dis.REF.james.2007.2821">James et al 2007</a>]. A subsequent <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> pregnancy in one family with DOORS syndrome was terminated due to an elevated nuchal translucency of 5.1 mm at 12 weeks' estimated gestational age [<a class="bk_pop" href="#tbc1d24-dis.REF.balestrini.2016.77">Balestrini et al 2016</a>].</p></div><div id="tbc1d24-dis.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="tbc1d24-dis.Genetic_Counseling"><h2 id="_tbc1d24-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="tbc1d24-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Most <i>TBC1D24</i>-related disorders (DOORS syndrome, FIME, PME, EIEE16, and DFNB86) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="tbc1d24-dis.Risk_to_Family_Members__Auto"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are typically asymptomatic and are not at risk of developing an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <i>TBC1D24</i>-related disorder. It is possible that some heterozygotes (carriers) could have an elevated susceptibility to seizure disorders related to certain <i>TBC1D24</i> pathogenic variants, but <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation is lacking and no risk estimates are available.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals with <i>TBC1D24</i>-related DOORS syndrome, <i>TBC1D24</i>-related PME, and EIEE16 have not reproduced.</div></li><li class="half_rhythm"><div>The offspring of an individual with a FIME or DFNB86 are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TBC1D24</i>.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>TBC1D24</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="tbc1d24-dis.Carrier_Heterozygote_Detecti"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>TBC1D24</i> pathogenic variants in the family.</p></div><div id="tbc1d24-dis.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#tbc1d24-dis.Evaluation_of_Relatives_at_R">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p>The following points are noteworthy:</p><ul><li class="half_rhythm"><div>Communication with individuals who are members of the Deaf community and who sign requires the services of a skilled interpreter.</div></li><li class="half_rhythm"><div>Members of the Deaf community may view deafness as a distinguishing characteristic and not as a handicap, impairment, or medical condition requiring a "treatment" or "cure," or to be "prevented."</div></li><li class="half_rhythm"><div>Many deaf people are interested in obtaining information about the cause of their own deafness, including information on medical, educational, and social services, rather than information about prevention, reproduction, or family planning. It is, therefore, important to ascertain and address the questions and concerns of the family/individual.</div></li><li class="half_rhythm"><div>The use of certain terms is preferred: probability or chance vs risk; deaf and hard-of-hearing vs hearing impaired. Terms such as "abnormal" should be avoided.</div></li></ul><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="tbc1d24-dis.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>TBC1D24</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="tbc1d24-dis.Resources"><h2 id="_tbc1d24-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy Information Page</a></div></li></ul></div><div id="tbc1d24-dis.Molecular_Genetics"><h2 id="_tbc1d24-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="tbc1d24-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>TBC1D24-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_tbc1d24-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_tbc1d24-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_tbc1d24-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_tbc1d24-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_tbc1d24-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_tbc1d24-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_tbc1d24-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57465" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TBC1D24</i></a></td><td headers="hd_b_tbc1d24-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57465" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_tbc1d24-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9ULP9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TBC1 domain family member 24</a></td><td headers="hd_b_tbc1d24-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/TBC1D24" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TBC1D24 @ LOVD</a></td><td headers="hd_b_tbc1d24-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TBC1D24" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TBC1D24</a></td><td headers="hd_b_tbc1d24-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TBC1D24[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TBC1D24</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="tbc1d24-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="tbc1d24-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for TBC1D24-Related Disorders (<a href="/omim/220500,605021,613577,614617,615338,616044" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/220500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">220500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605021" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605021</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613577" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613577</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TBC1 DOMAIN FAMILY, MEMBER 24; TBC1D24</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614617" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614617</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615338" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615338</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616044" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616044</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65</td></tr></tbody></table></div></div><p><b>Gene structure.</b> Transcript variant 1 (<a href="/nuccore/NM_001199107.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001199107.1</a>) encodes the longest isoform, and is composed of eight exons, with <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 being noncoding. Exon 3 is spliced out in isoform 2 (encoded by transcript <a href="/nuccore/NM_020705.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020705.2</a>), which is expressed predominantly in non-neural tissues [<a class="bk_pop" href="#tbc1d24-dis.REF.guven.2013.199">Guven &#x00026; Tolun 2013</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK274566/#tbc1d24-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants</b></p><div id="tbc1d24-dis.T.tbc1d24_pathogenic_variant" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>TBC1D24</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK274566/table/tbc1d24-dis.T.tbc1d24_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbc1d24-dis.T.tbc1d24_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.119G&#x0003e;T</td><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg40Leu</td><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001199107.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001199107<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_001186036.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001186036<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.208G&#x0003e;T</td><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp70Tyr</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.404C&#x0003e;T</td><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro135Leu</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.533C&#x0003e;T</td><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser178Leu</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.724C&#x0003e;T</td><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg242Cys</td></tr><tr><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1008delT</td><td headers="hd_h_tbc1d24-dis.T.tbc1d24_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His336GlnfsTer12</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> TBC1D24 is a Tre2&#x02013;Bub2&#x02013;Cdc16 (TBC) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing RAB GTPase-activating protein, which catalyzes the hydrolysis of GTP by small GTPases, thus regulating the proper transport of intracellular vesicles. TBC1D24 is the only TBC/RabGAP protein with a TLDc domain (TBC, LysM, Domain catalytic) of unknown function but thought to be involved in oxidative stress resistance and perhaps to have some enzymatic activity.</p><p>TBC1D24 has been demonstrated to interact with ARF6 when both proteins are overexpressed in cell culture [<a class="bk_pop" href="#tbc1d24-dis.REF.falace.2010.365">Falace et al 2010</a>, <a class="bk_pop" href="#tbc1d24-dis.REF.falace.2014.2337">Falace et al 2014</a>]. In <i>C. elegans</i>, C31H2.1 (a TBC1D24 ortholog) was implicated in synaptic function by an RNAi screen [<a class="bk_pop" href="#tbc1d24-dis.REF.sieburth.2005.510">Sieburth et al 2005</a>]. In <i>Drosophila</i>, the ortholog Skywalker (Sky) facilitates endosomal trafficking in synaptic vesicles by facilitating GTP hydrolysis by Rab35, thus controlling synaptic vesicle rejuvenation and neurotransmitter release [<a class="bk_pop" href="#tbc1d24-dis.REF.uytterhoeven.2011.117">Uytterhoeven et al 2011</a>]. Analysis of the crystal structure of Sky identified a cationic pocket that is preserved in human TBC1D24. This pocket is necessary for binding to the lipid membrane via phosphoinositides phosphorylated at the 4 and 5 positions [<a class="bk_pop" href="#tbc1d24-dis.REF.fischer.2016.965">Fischer et al 2016</a>]. Whether human TBC1D24 is able to also facilitate Rab protein-mediated GTP hydrolysis remains to be determined.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TBC1D24</i>-related disorders that are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner are thought to be the result of reduced function or loss of function of TBC1D24. Abrogation of the cationic pocket by introducing two human pathogenic variants p.Arg40 and p.Arg242 led to impaired synaptic vesicle trafficking and seizures in <i>Drosophila</i> [<a class="bk_pop" href="#tbc1d24-dis.REF.fischer.2016.965">Fischer et al 2016</a>]. Functional studies of other causative variants are limited and to date, no studies have been conducted examining the variant causing <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hearing loss, p.Ser178Leu.</p></div><div id="tbc1d24-dis.References"><h2 id="_tbc1d24-dis_References_">References</h2><div id="tbc1d24-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.afawi.2013.240">Afawi Z, Mandelstam S, Korczyn AD, Kivity S, Walid S, Shalata A, Oliver KL, Corbett M, Gecz J, Berkovic SF, Jackson GD. TBC1D24 mutation associated with focal epilepsy, cognitive impairment and a distinctive cerebro-cerebellar malformation. <span><span class="ref-journal">Epilepsy Res. </span>2013;<span class="ref-vol">105</span>:240–4.</span> [<a href="/pubmed/23517570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23517570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.azaiez.2014.819">Azaiez H, Booth KT, Bu F, Huygen P, Shibata SB, Shearer AE, Kolbe D, Meyer N, Black-Ziegelbein EA, Smith RJ. TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:819–23.</span> [<a href="/pmc/articles/PMC4267685/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4267685</span></a>] [<a href="/pubmed/24729539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24729539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.bakhchane.2015.e0138072">Bakhchane A, Charif M, Salime S, Boulouiz R, Nahili H, Roky R, Lenaers G, Barakat A. Recessive TBC1D24 mutations are frequent in Moroccan non-syndromic hearing loss pedigrees. <span><span class="ref-journal">PLoS One. </span>2015;<span class="ref-vol">10</span>:e0138072.</span> [<a href="/pmc/articles/PMC4570774/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4570774</span></a>] [<a href="/pubmed/26371875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26371875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.balestrini.2016.77">Balestrini S, Milh M, Castiglioni C, L&#x000fc;thy K, Finelli MJ, Verstreken P, Cardon A, Stra&#x0017e;i&#x00161;ar BG, Holder JL, Lesca G, Mancardi MM. TBC1D24 genotype&#x02013;phenotype correlation Epilepsies and other neurologic features. <span><span class="ref-journal">Neurology. </span>2016;<span class="ref-vol">87</span>:77–85.</span> [<a href="/pmc/articles/PMC4932231/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4932231</span></a>] [<a href="/pubmed/27281533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27281533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.banuelos.2017.553">Banuelos E, Ramsey K, Belnap N, Krishnan M, Balak C, Szelinger S, Siniard AL, Russell M, Richholt R, De Both M, Piras I. Case report: novel mutations in TBC1D24 are associated with autosomal dominant tonic-clonic and myoclonic epilepsy and recessive Parkinsonism, psychosis, and intellectual disability. <span><span class="ref-journal">F1000Res. </span>2017;<span class="ref-vol">6</span>:553.</span> [<a href="/pmc/articles/PMC5473401/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5473401</span></a>] [<a href="/pubmed/28663785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28663785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.berg.2010.676">Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Mosh&#x000e9; SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:676–85.</span> [<a href="/pubmed/20196795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20196795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.brunklaus.2012.2329">Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:2329–36.</span> [<a href="/pubmed/22719002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22719002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.campeau.2014.44">Campeau PM, Kasperaviciute D, Lu JT, Burrage LC, Kim C, Hori M, Powell BR, Stewart F, F&#x000e9;lix TM, van den Ende J, Wisniewska M, Kayserili H, Rump P, Nampoothiri S, Aftimos S, Mey A, Nair LD, Begleiter ML, De Bie I, Meenakshi G, Murray ML, Repetto GM, Golabi M, Blair E, Male A, Giuliano F, Kariminejad A, Newman WG, Bhaskar SS, Dickerson JE, Kerr B, Banka S, Giltay JC, Wieczorek D, Tostevin A, Wiszniewska J, Cheung SW, Hennekam RC, Gibbs RA, Lee BH, Sisodiya SM. The genetic basis of DOORS syndrome: an exome-sequencing study. <span><span class="ref-journal">Lancet Neurol. </span>2014;<span class="ref-vol">13</span>:44–58.</span> [<a href="/pmc/articles/PMC3895324/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3895324</span></a>] [<a href="/pubmed/24291220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24291220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.cantwell.1975.261">Cantwell RJ. Congenital sensori-neural deafness associated with onycho-osteo dystrophy and mental retardation (D.O.O.R. syndrome). <span><span class="ref-journal">Humangenetik. </span>1975;<span class="ref-vol">26</span>:261–5.</span> [<a href="/pubmed/1132883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1132883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.corbett.2010.371">Corbett MA, Bahlo M, Jolly L, Afawi Z, Gardner AE, Oliver KL, Tan S, Coffey A, Mulley JC, Dibbens LM, Simri W, Shalata A, Kivity S, Jackson GD, Berkovic SF, Gecz J. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:371–5.</span> [<a href="/pmc/articles/PMC2933342/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2933342</span></a>] [<a href="/pubmed/20797691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20797691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.de_falco.2001.1541">de Falco FA, Majello L, Santangelo R, Stabile M, Bricarelli FD, Zara F. Familial infantile myoclonic epilepsy: clinical features in a large kindred with autosomal recessive inheritance. <span><span class="ref-journal">Epilepsia. </span>2001;<span class="ref-vol">42</span>:1541–8.</span> [<a href="/pubmed/11879364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11879364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.de_kovel.2016.568">de Kovel CG, Brilstra EH, Kempen MJ, Slot R, Nijman IJ, Afawi Z, De Jonghe P, Dj&#x000e9;mi&#x000e9; T, Guerrini R, Hardies K, Helbig I. Targeted sequencing of 351 candidate genes for epileptic encephalopathy in a large cohort of patients. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2016;<span class="ref-vol">4</span>:568–80.</span> [<a href="/pmc/articles/PMC5023942/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5023942</span></a>] [<a href="/pubmed/27652284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27652284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.duru.2010.207">Duru N, Iseri SA, Selcuk N, Tolun A. Early-onset progressive myoclonic epilepsy with dystonia mapping to 16pter-p13.3. <span><span class="ref-journal">J Neurogenet. </span>2010;<span class="ref-vol">24</span>:207–15.</span> [<a href="/pubmed/21087195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21087195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.engel.2001.796">Engel J Jr. International League Against E. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. <span><span class="ref-journal">Epilepsia. </span>2001;<span class="ref-vol">42</span>:796–803.</span> [<a href="/pubmed/11422340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11422340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.eronen.1985.281">Eronen M, Somer M, Gustafsson B, Holmberg C, Fraser FC, Preus M. New syndrome: A digito-reno-cerebral syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1985;<span class="ref-vol">22</span>:281–5.</span> [<a href="/pubmed/4050858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4050858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.falace.2014.2337">Falace A, Buhler E, Fadda M, Watrin F, Lippiello P, Pallesi-Pocachard E, Baldelli P, Benfenati F, Zara F, Represa A, Fassio A, Cardoso C. TBC1D24 regulates neuronal migration and maturation through modulation of the ARF6-dependent pathway. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2014;<span class="ref-vol">111</span>:2337–42.</span> [<a href="/pmc/articles/PMC3926028/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3926028</span></a>] [<a href="/pubmed/24469796" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24469796</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.falace.2010.365">Falace A, Filipello F, La Padula V, Vanni N, Madia F, De Pietri Tonelli D, de Falco FA, Striano P, Dagna Bricarelli F, Minetti C, Benfenati F, Fassio A, Zara F. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:365–70.</span> [<a href="/pmc/articles/PMC2933335/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2933335</span></a>] [<a href="/pubmed/20727515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20727515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.fischer.2016.965">Fischer B, L&#x000fc;thy K, Paesmans J, De Koninck C, Maes I, Swerts J, Kuenen S, Uytterhoeven V, Verstreken P, Vers&#x000e9;es W. Skywalker-TBC1D24 has a lipid-binding pocket mutated in epilepsy and required for synaptic function. <span><span class="ref-journal">Nat Struct Mol Biol. </span>2016;<span class="ref-vol">23</span>:965–73.</span> [<a href="/pubmed/27669036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27669036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.girish.2011.479">Girish M, Mujawar N, Salodkar A. DOOR syndrome. <span><span class="ref-journal">Indian Pediatr. </span>2011;<span class="ref-vol">48</span>:479–81.</span> [<a href="/pubmed/21743113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21743113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.guven.2013.199">Guven A, Tolun A. TBC1D24 truncating mutation resulting in severe neurodegeneration. <span><span class="ref-journal">J Med Genet. </span>2013;<span class="ref-vol">50</span>:199–202.</span> [<a href="/pubmed/23343562" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23343562</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.james.2007.2821">James AW, Miranda SG, Culver K, Hall BD, Golabi M. DOOR syndrome: clinical report, literature review and discussion of natural history. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:2821–31.</span> [<a href="/pubmed/17994565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17994565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.le_merrer.1992.196">Le Merrer M, David A, Goutieres F, Briard ML. Digito-reno-cerebral syndrome: confirmation of Eronen syndrome. <span><span class="ref-journal">Clin Genet. </span>1992;<span class="ref-vol">42</span>:196–8.</span> [<a href="/pubmed/1424243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1424243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.lozano.2016.3207">Lozano R, Herman K, Rothfuss M, Rieger H, Bayrak-Toydemir P, Aprile D, Fruscione F, Zara F, Fassio A. Clinical intrafamilial variability in lethal familial neonatal seizure disorder caused by TBC1D24 mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:3207–14.</span> [<a href="/pubmed/27541164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27541164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.mefford.2011.974">Mefford HC, Yendle SC, Hsu C, Cook J, Geraghty E, McMahon JM, Eeg-Olofsson O, Sadleir LG, Gill D, Ben-Zeev B, Lerman-Sagie T, Mackay M, Freeman JL, Andermann E, Pelakanos JT, Andrews I, Wallace G, Eichler EE, Berkovic SF, Scheffer IE. Rare copy number variants are an important cause of epileptic encephalopathies. <span><span class="ref-journal">Ann Neurol. </span>2011;<span class="ref-vol">70</span>:974–85.</span> [<a href="/pmc/articles/PMC3245646/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3245646</span></a>] [<a href="/pubmed/22190369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22190369</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.milh.2013.869">Milh M, Falace A, Villeneuve N, Vanni N, Cacciagli P, Assereto S, Nabbout R, Benfenati F, Zara F, Chabrol B, Villard L, Fassio A. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:869–72.</span> [<a href="/pubmed/23526554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23526554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.muona.2015.39">Muona M, Berkovic SF, Dibbens LM, Oliver KL, Maljevic S, Bayly MA, Joensuu T, Canafoglia L, Franceschetti S, Michelucci R, Markkinen S, Heron SE, Hildebrand MS, Andermann E, Andermann F, Gambardella A, Tinuper P, Licchetta L, Scheffer IE, Criscuolo C, Filla A, Ferlazzo E, Ahmad J, Ahmad A, Baykan B, Said E, Topcu M, Riguzzi P, King MD, Ozkara C, Andrade DM, Engelsen BA, Crespel A, Lindenau M, Lohmann E, Saletti V, Massano J, Privitera M, Espay AJ, Kauffmann B, Duchowny M, M&#x000f8;ller RS, Straussberg R, Afawi Z, Ben-Zeev B, Samocha KE, Daly MJ, Petrou S, Lerche H, Palotie A, Lehesjoki AE. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. <span><span class="ref-journal">Nat Genet. </span>2015;<span class="ref-vol">47</span>:39–46.</span> [<a href="/pmc/articles/PMC4281260/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4281260</span></a>] [<a href="/pubmed/25401298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25401298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.nomura.2009.75">Nomura T, Koyama N, Yokoyama M, Awaya A, Yokochi K. DOOR syndrome concomitant with non-convulsive status epilepticus and hyperintense cerebellar cortex on T2-weighted imaging. <span><span class="ref-journal">Brain Dev. </span>2009;<span class="ref-vol">31</span>:75–8.</span> [<a href="/pubmed/18440741" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18440741</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.patton.1987.207">Patton MA, Krywawych S, Winter RM, Brenton DP, Baraitser M. DOOR syndrome (deafness, onycho-osteodystrophy, and mental retardation): elevated plasma and urinary 2-oxoglutarate in three unrelated patients. <span><span class="ref-journal">Am J Med Genet. </span>1987;<span class="ref-vol">26</span>:207–15.</span> [<a href="/pubmed/3812564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3812564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.qazi.1984.391">Qazi QH, Nangia BS. Abnormal distal phalanges and nails, deafness, mental retardation, and seizure disorder: A new familial syndrome. <span><span class="ref-journal">J Pediatr. </span>1984;<span class="ref-vol">104</span>:391–4.</span> [<a href="/pubmed/6707793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6707793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.rehman.2014.144">Rehman AU, Santos-Cortez RL, Morell RJ, Drummond MC, Ito T, Lee K, Khan AA, Basra MA, Wasif N, Ayub M, Ali RA, Raza S. University of Washington Center for Mendelian Genomics, Nickerson DA, Shendure J, Bamshad M, Riazuddin S, Billington N, Khan SN, Friedman PL, Griffith AJ, Ahmad W, Riazuddin S, Leal SM, Friedman TB. Mutations in TBC1D24, a gene associated with epilepsy, also cause nonsyndromic deafness DFNB86. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">94</span>:144–52.</span> [<a href="/pmc/articles/PMC3882911/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3882911</span></a>] [<a href="/pubmed/24387994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24387994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.sieburth.2005.510">Sieburth D, Ch'ng Q, Dybbs M, Tavazoie M, Kennedy S, Wang D, Dupuy D, Rual JF, Hill DE, Vidal M, Ruvkun G, Kaplan JM. Systematic analysis of genes required for synapse structure and function. <span><span class="ref-journal">Nature. </span>2005;<span class="ref-vol">436</span>:510–7.</span> [<a href="/pubmed/16049479" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16049479</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.stra_i_ar.2015.251">Stra&#x0017e;i&#x00161;ar B.G., Neubauer D., Panjan D.P., Writzl K. Early-onset epileptic encephalopathy with hearing loss in two siblings with TBC1D24 recessive mutations. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2015;<span class="ref-vol">19</span>(2):251–256.</span> [<a href="/pubmed/25557349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25557349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.uytterhoeven.2011.117">Uytterhoeven V, Kuenen S, Kasprowicz J, Miskiewicz K, Verstreken P. Loss of skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins. <span><span class="ref-journal">Cell. </span>2011;<span class="ref-vol">145</span>:117–32.</span> [<a href="/pubmed/21458671" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21458671</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.van_bever.2007.763">van Bever Y, Balemans W, Duval EL, Jespers A, Eyskens F, van Hul W, Courtens W. Exclusion of OGDH and BMP4 as candidate genes in two siblings with autosomal recessive DOOR syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:763–7.</span> [<a href="/pubmed/17343268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17343268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.yu.2013.124934">Yu JY, Pearl PL. Metabolic causes of epileptic encephalopathy. <span><span class="ref-journal">Epilepsy Res Treat. </span>2013;<span class="ref-vol">2013</span>:124934.</span> [<a href="/pmc/articles/PMC3674738/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3674738</span></a>] [<a href="/pubmed/23762547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23762547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.zara.2000.1552">Zara F, Gennaro E, Stabile M, Carbone I, Malacarne M, Majello L, Santangelo R, de Falco FA, Bricarelli FD. Mapping of a locus for a familial autosomal recessive idiopathic myoclonic epilepsy of infancy to chromosome 16p13. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1552–7.</span> [<a href="/pmc/articles/PMC1378007/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1378007</span></a>] [<a href="/pubmed/10741954" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10741954</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbc1d24-dis.REF.zhang.2014.814">Zhang L, Hu L, Chai Y, Pang X, Yang T, Wu H. A dominant mutation in the stereocilia-expressing gene TBC1D24 is a probable cause for nonsyndromic hearing impairment. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:814–8.</span> [<a href="/pubmed/24729547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24729547</span></a>]</div></li></ul></div></div><div id="tbc1d24-dis.Chapter_Notes"><h2 id="_tbc1d24-dis_Chapter_Notes_">Chapter Notes</h2><div id="tbc1d24-dis.Author_Notes"><h3>Author Notes</h3><p><a href="http://recherche.chusj.org/en/Chercheurs/Bio?id=cf14e904-cdaa-4edd-b9a1-daf6fbb71a2c" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Philippe M Campeau</a> is Clinical Assistant Professor in Pediatrics at the Sainte-Justine Hospital of the University of Montreal. He is a clinical geneticist with interest in skeletal dysplasias and inborn errors of metabolism, and a principal investigator whose laboratory focuses on understanding the pathophysiology of newly identified skeletal dysplasia genes.</p></div><div id="tbc1d24-dis.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to thank the families who participated in our study on DOORS syndrome and made this work possible.</p></div><div id="tbc1d24-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 December 2017 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 February 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>31 July 2014 (pmc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK274566</span><span class="label">PMID: <a href="/pubmed/25719194" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">25719194</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/tardbp-als/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tfr2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK274566&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK274566/?report=reader">PubReader</a></li><li><a href="/books/NBK274566/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK274566" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK274566" style="display:none" title="Cite this Page"><div class="bk_tt">Mucha BE, Hennekam RCM, Sisodiya S, et al. TBC1D24-Related Disorders. 2015 Feb 26 [Updated 2017 Dec 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK274566/pdf/Bookshelf_NBK274566.pdf">PDF version of this page</a> (500K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#tbc1d24-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#tbc1d24-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#tbc1d24-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#tbc1d24-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#tbc1d24-dis.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#tbc1d24-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#tbc1d24-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#tbc1d24-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#tbc1d24-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#tbc1d24-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#tbc1d24-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#tbc1d24-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57465[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TBC1D24</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3396364" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3396364" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3396364" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3396364" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301601" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mole SE, Williams RE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301750" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tranebjærg L, Barrett T, Rendtorff ND. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24741716" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gorman GS, Taylor RW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=25719194" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=25719194" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04118575f66d18aae43326">TBC1D24-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">TBC1D24-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:48:53-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AD381E03F7AC10000000009EE035F&amp;ncbi_session=CE8AD381E0411851_2542SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK274566%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK274566&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK274566/&amp;ncbi_pagename=TBC1D24-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AD381E0411851_2542SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>